Evidence map›Paper›PMID 33859262›Full record

ArticleScientific reports2021

Changes in the gene expression profile during spontaneous migraine attacks.

Lisette J A Kogelman, Katrine Falkenberg, Alfonso Buil, Pau Erola, Julie Courraud, Susan Svane Laursen, Tom Michoel, Jes Olesen, Thomas F Hansen

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 23 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. The interictal transcriptomic map of migraine without aura.The journal of headache and pain · 2025
    Article
  7. Article
  8. Review
  9. Role of TNFPain research & management · 2024
    Review
  10. Article
  11. Article
  12. Network-based approaches for modeling disease regulation and progression.Computational and structural biotechnology journal · 2023
    Review
  13. Article
  14. Review
  15. Review
  16. Dural Immune Cells, CGRP, and Migraine.Frontiers in neurology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 3 countries.

Lisette J A Kogelman *Danish Headache Center, Department of Neurology, Rigshospitalet Glostrup, Glostrup, Denmark. Lisette.kogelman@regionh.dk.
Katrine Falkenberg *Danish Headache Center, Department of Neurology, Rigshospitalet Glostrup, Glostrup, Denmark.
Alfonso BuilInstitute for Biological Psychiatry, Mental Health Center Sct. Hans, Roskilde, Denmark.
Pau ErolaMRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
Julie CourraudDepartment of Clinical Biochemistry and Immunology, Statens Serum Institute Copenhagen, Copenhagen, Denmark.
Susan Svane LaursenDepartment of Clinical Biochemistry and Immunology, Statens Serum Institute Copenhagen, Copenhagen, Denmark.
Tom MichoelComputational Biology Unit, Department of Informatics, University of Bergen, Bergen, Norway.
Jes OlesenDanish Headache Center, Department of Neurology, Rigshospitalet Glostrup, Glostrup, Denmark.
Thomas F HansenDanish Headache Center, Department of Neurology, Rigshospitalet Glostrup, Glostrup, Denmark. thomas.hansen@regionh.dk.
Glostrup Hospital · DKStatens Serum Institut · DKMRC Epidemiology Unit · GBNovo Nordisk Foundation · DKSankt Hans Hospital · DKUniversity of Bergen · NO

Funding

Cancer Research UK 19169Cancer Research UK C18281/A19169Medical Research Council MC_UU_00011/4
6 · The paper itself

Abstract

Migraine attacks are delimited, allowing investigation of changes during and outside attack. Gene expression fluctuates according to environmental and endogenous events and therefore, we hypothesized that changes in RNA expression during and outside a spontaneous migraine attack exist which are specific to migraine. Twenty-seven migraine patients were assessed during a spontaneous migraine attack, including headache characteristics and treatment effect. Blood samples were taken during attack, two hours after treatment, on a headache-free day and after a cold pressor test. RNA-Sequencing, genotyping, and steroid profiling were performed. RNA-Sequences were analyzed at gene level (differential expression analysis) and at network level, and genomic and transcriptomic data were integrated. We found 29 differentially expressed genes between 'attack' and 'after treatment', after subtracting non-migraine specific genes, that were functioning in fatty acid oxidation, signaling pathways and immune-related pathways. Network analysis revealed mechanisms affected by changes in gene interactions, e.g. 'ion transmembrane transport'. Integration of genomic and transcriptomic data revealed pathways related to sumatriptan treatment, i.e. '5HT1 type receptor mediated signaling pathway'. In conclusion, we uniquely investigated intra-individual changes in gene expression during a migraine attack. We revealed both genes and pathways potentially involved in the pathophysiology of migraine and/or migraine treatment.

Indexed as

AdolescentAdultAgedEpistasis, GeneticFemaleHumansMaleMiddle AgedMigraine DisordersRNASumatriptanTranscriptomeYoung AdultRNASumatriptan

Identifiers

PMID33859262
PMCPMC8050061
OpenAlexW3155832635

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.